Biomarker study confirms HNL Dimer’s efficacy in monitoring sepsis treatment

Biomarker study confirms HNL Dimer’s efficacy in monitoring sepsis treatment

The biomarker human neutrophil lipocalin HNL was previously shown to be a useful indicator of bacterial infections. Now, the dimeric form of HNL may also be used to effectively monitor the success of antibiotic treatment in sepsis.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *